Advertisement
Screener

NovaBridge Biosciences (NBP) Form 6-K: Report of foreign private issuer

1.6 / 5 stars · 9/29 Roast Me

Add as a preferred source on Google

NovaBridge Biosciences Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2026-09-08: Form 6-K; Period of report 2026-09-08; Description 6-K; Document 6-k_agm.htm.
  • 2026-09-08: Form 6-K; Period of report 2026-09-08; Description 6-K; Document 6-k_new_director_martin.htm.
  • 2026-08-20: Form 6-K; Period of report 2026-06-30; Description 6-K; Document nbp-20260630.htm.
  • 2026-08-20: Form 6-K; Period of report 2026-08-20; Description 6-K; Document nbp_-_6-k_for_corporate_.htm.
FiledFormPeriod of reportDescriptionDocument
2026-09-086-K2026-09-086-K6-k_agm.htm
2026-09-086-K2026-09-086-K6-k_new_director_martin.htm
2026-08-206-K2026-06-306-Knbp-20260630.htm
2026-08-206-K2026-08-206-Knbp_-_6-k_for_corporate_.htm
2026-07-246-K2026-07-246-K6-k_-_2026_agm.htm
2026-07-176-K2026-07-136-K6-k_-_2026_esop.htm
2026-06-296-K2026-06-296-K6-k_-_appointment_of_sri.htm
2026-06-166-K2026-06-166-Knbp_-_6-k_-_change_of_au.htm
2026-06-166-K2026-06-166-K6-k_-_fda_ftd.htm
2026-04-226-K2026-04-226-Kmark_hagler_pr_-_04-22-2.htm
2026-04-076-K2026-04-076-K20-f_pr_and_ir_deck_-_04.htm
2026-03-166-K2026-03-166-Kgiva_fda_pr_-_03-16-26.htm
2026-03-096-K2026-03-096-Kvis-101_pr_and_decks_-_0.htm
2026-03-036-K2026-03-036-Kvisara_cr_pr_-_03-03-26.htm
2026-02-256-K2026-02-256-Kupdated_ir_deck_-_02-25-.htm
2026-02-196-K2026-02-196-Kcunningham_pr_2-19-26.htm
2026-02-176-K2026-02-176-Kgiva_ph_2_fpi_pr_-_02-17.htm
2026-02-066-K/A2026-02-066-K/Air_deck_update_-_2-6-26_.htm
2026-02-066-K2026-02-066-Kupdated_ir_deck_-_02-06-.htm
2026-01-226-K2026-01-226-Ksf_market_purchase_-_01-.htm
2026-01-226-K2026-01-226-Ksc_market_purchase_-_01-.htm
2026-01-166-K2026-01-166-Kfw_market_purchase_-_01-.htm
2026-01-066-K2026-01-066-Kgiva_pr_and_ir_deck_-_01.htm
Advertisement